Sotera Health Quarterly Balance Sheets Chart
Quarterly
|
Annual
Sotera Health Quarterly Balance Sheets Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||||
current assets: | |||||||||||||||||||
cash and cash equivalents | 332,437,000 | 304,390,000 | 277,242,000 | 306,738,000 | 246,084,000 | 261,133,000 | 296,407,000 | 244,959,000 | 262,700,000 | 647,948,000 | 395,214,000 | 163,975,000 | 139,564,000 | 121,440,000 | 106,917,000 | 114,912,000 | 156,217,000 | 108,009,000 | 102,447,000 |
restricted cash short-term | 1,835,000 | 1,691,000 | 1,623,000 | 1,744,000 | 1,674,000 | 1,687,000 | 5,247,000 | 7,575,000 | 7,790,000 | 12,232,000 | 1,080,000 | 986,000 | 1,054,000 | 6,000 | 7,000 | 7,000 | 7,000 | 7,000 | 7,000 |
accounts receivable | 136,557,000 | 128,066,000 | 140,327,000 | 130,121,000 | 123,659,000 | 111,069,000 | 147,696,000 | 118,396,000 | 117,307,000 | 109,163,000 | 118,482,000 | 111,613,000 | 119,852,000 | 114,763,000 | 108,183,000 | 96,094,000 | 118,405,000 | 96,393,000 | 91,735,000 |
inventories | 59,949,000 | 61,045,000 | 49,158,000 | 53,647,000 | 57,872,000 | 51,342,000 | 48,316,000 | 37,924,000 | 42,102,000 | 46,736,000 | 37,145,000 | 37,153,000 | 39,652,000 | 45,701,000 | 54,288,000 | 37,496,000 | 35,721,000 | 33,375,000 | 34,093,000 |
prepaid expenses and other current assets | 66,024,000 | 54,663,000 | 51,031,000 | 57,421,000 | 56,652,000 | 53,663,000 | 53,846,000 | 84,201,000 | 90,910,000 | 87,303,000 | 80,995,000 | 81,673,000 | 81,173,000 | 83,956,000 | 71,923,000 | 67,707,000 | 67,942,000 | 69,758,000 | 64,964,000 |
income taxes receivable | 11,373,000 | 5,135,000 | 6,656,000 | 13,942,000 | 11,736,000 | 8,285,000 | 5,732,000 | 26,591,000 | 25,883,000 | 20,417,000 | 12,094,000 | 25,334,000 | 17,386,000 | 5,694,000 | 4,643,000 | 21,089,000 | 22,813,000 | 20,825,000 | 21,769,000 |
total current assets | 608,175,000 | 554,990,000 | 526,037,000 | 563,613,000 | 497,677,000 | 487,179,000 | 557,244,000 | 519,646,000 | 546,692,000 | 923,799,000 | 645,010,000 | 420,734,000 | 398,681,000 | 371,560,000 | 345,961,000 | 337,305,000 | 401,105,000 | 328,367,000 | 315,015,000 |
property, plant, and equipment | 1,080,399,000 | 1,046,449,000 | 1,036,892,000 | 1,026,028,000 | 994,614,000 | 979,422,000 | 946,914,000 | 884,385,000 | 859,138,000 | 816,164,000 | 774,527,000 | 704,406,000 | 699,571,000 | 669,161,000 | 650,797,000 | 624,341,000 | 623,513,000 | 611,620,000 | 609,814,000 |
operating lease assets | 31,524,000 | 27,072,000 | 27,551,000 | 29,266,000 | 24,272,000 | 22,517,000 | 24,037,000 | 24,672,000 | 25,179,000 | 24,941,000 | 26,481,000 | 27,194,000 | 29,853,000 | 36,984,000 | 39,946,000 | 42,682,000 | 45,147,000 | 47,117,000 | 45,963,000 |
deferred income taxes | 4,466,000 | 2,979,000 | 2,865,000 | 4,946,000 | 4,749,000 | 4,883,000 | 4,993,000 | 4,043,000 | 4,157,000 | 4,165,000 | 4,101,000 | 5,087,000 | 5,425,000 | 5,769,000 | 5,885,000 | 8,015,000 | 8,194,000 | 8,088,000 | 8,424,000 |
post-retirement assets | 48,272,000 | 44,262,000 | 42,524,000 | 32,916,000 | 30,721,000 | 29,502,000 | 28,482,000 | 39,342,000 | 39,004,000 | 36,915,000 | 35,570,000 | 9,856,000 | 8,788,000 | ||||||
other assets | 39,282,000 | 37,094,000 | 37,053,000 | 35,436,000 | 39,541,000 | 42,881,000 | 41,242,000 | 34,563,000 | 34,082,000 | 32,909,000 | 38,983,000 | 47,131,000 | 38,308,000 | 27,488,000 | 12,866,000 | 9,211,000 | 8,834,000 | 9,281,000 | 9,304,000 |
other intangible assets | 300,109,000 | 300,300,000 | 317,653,000 | 351,977,000 | 367,938,000 | 390,457,000 | 416,318,000 | 429,112,000 | 456,120,000 | 471,860,000 | 491,265,000 | 503,755,000 | 543,057,000 | 582,144,000 | 598,844,000 | 608,641,000 | 640,787,000 | 656,572,000 | 643,366,000 |
goodwill | 1,104,502,000 | 1,084,382,000 | 1,081,073,000 | 1,104,555,000 | 1,098,306,000 | 1,102,851,000 | 1,111,190,000 | 1,100,811,000 | 1,110,498,000 | 1,103,420,000 | 1,101,768,000 | 1,092,469,000 | 1,116,002,000 | 1,125,828,000 | 1,120,320,000 | 1,103,148,000 | 1,114,176,000 | 1,106,728,000 | 1,115,936,000 |
total assets | 3,216,729,000 | 3,097,528,000 | 3,071,648,000 | 3,148,737,000 | 3,057,818,000 | 3,059,692,000 | 3,130,420,000 | 3,036,574,000 | 3,074,870,000 | 3,414,173,000 | 3,117,705,000 | 2,810,632,000 | 2,839,685,000 | 2,835,769,000 | 2,789,502,000 | 2,742,739,000 | 2,851,129,000 | 2,777,000,000 | 2,761,279,000 |
liabilities and equity | |||||||||||||||||||
current liabilities: | |||||||||||||||||||
accounts payable | 63,660,000 | 70,106,000 | 55,098,000 | 70,754,000 | 64,487,000 | 61,576,000 | 71,039,000 | 57,125,000 | 55,580,000 | 61,939,000 | 74,139,000 | 60,730,000 | 65,271,000 | 55,221,000 | 72,868,000 | 51,814,000 | 63,147,000 | 57,174,000 | 52,400,000 |
accrued liabilities | 143,542,000 | 113,803,000 | 90,463,000 | 82,885,000 | 69,054,000 | 61,774,000 | 122,471,000 | 106,371,000 | 103,450,000 | 496,791,000 | 490,130,000 | 56,762,000 | 52,658,000 | 60,459,000 | 61,861,000 | 54,497,000 | 57,165,000 | 56,373,000 | 60,518,000 |
deferred revenues | 11,526,000 | 12,989,000 | 13,840,000 | 6,863,000 | |||||||||||||||
current portion of long-term debt | 14,820,000 | 14,811,000 | 14,803,000 | 14,795,000 | 11,092,000 | 4,808,000 | 4,797,000 | 5,235,000 | 5,225,000 | 4,031,000 | 197,119,000 | ||||||||
current portion of finance lease obligations | 3,237,000 | 3,039,000 | 2,923,000 | 2,822,000 | 2,767,000 | 1,490,000 | 8,771,000 | 8,398,000 | 8,605,000 | 8,588,000 | 1,722,000 | 1,591,000 | 1,615,000 | 1,342,000 | 1,160,000 | 1,339,000 | 1,103,000 | 1,108,000 | 1,173,000 |
current portion of operating lease obligations | 5,598,000 | 5,084,000 | 5,056,000 | 5,287,000 | 4,835,000 | 5,303,000 | 5,934,000 | 6,362,000 | 7,111,000 | 6,942,000 | 7,554,000 | 7,718,000 | 8,132,000 | 8,906,000 | 9,289,000 | 9,546,000 | 10,106,000 | 9,631,000 | 9,383,000 |
income taxes payable | 3,937,000 | 5,394,000 | 7,559,000 | 8,341,000 | 4,409,000 | 4,507,000 | 4,150,000 | 4,139,000 | 5,726,000 | 4,589,000 | 5,867,000 | 7,351,000 | 6,876,000 | 4,368,000 | 6,695,000 | 10,914,000 | 11,072,000 | 7,384,000 | 10,448,000 |
total current liabilities | 246,320,000 | 225,991,000 | 191,002,000 | 195,537,000 | 169,633,000 | 152,340,000 | 230,654,000 | 200,594,000 | 200,330,000 | 600,149,000 | 791,567,000 | 140,031,000 | 142,021,000 | 143,851,000 | 161,161,000 | 133,606,000 | 148,792,000 | 138,019,000 | 140,598,000 |
long-term debt | 2,202,651,000 | 2,205,355,000 | 2,208,100,000 | 2,210,815,000 | 2,213,518,000 | 2,223,674,000 | 2,222,789,000 | 2,221,987,000 | 1,746,555,000 | 1,745,548,000 | 1,742,578,000 | 1,838,133,000 | |||||||
finance lease obligations, less current portion | 95,420,000 | 94,216,000 | 95,286,000 | 97,934,000 | 93,518,000 | 90,858,000 | 63,793,000 | 63,219,000 | 61,283,000 | 61,735,000 | 56,955,000 | 54,935,000 | 57,140,000 | 40,014,000 | 40,877,000 | 38,014,000 | 33,446,000 | 33,432,000 | 34,939,000 |
operating lease obligations, less current portion | 27,988,000 | 23,979,000 | 24,465,000 | 25,953,000 | 21,353,000 | 19,132,000 | 20,087,000 | 20,674,000 | 20,538,000 | 20,561,000 | 21,577,000 | 22,174,000 | 24,546,000 | 31,065,000 | 33,017,000 | 35,378,000 | 37,354,000 | 39,806,000 | 38,941,000 |
noncurrent asset retirement obligations | 52,150,000 | 50,152,000 | 49,319,000 | 49,102,000 | 48,096,000 | 48,021,000 | 47,944,000 | 44,382,000 | 44,492,000 | 43,350,000 | 42,586,000 | 43,889,000 | 42,688,000 | 42,995,000 | 41,833,000 | 46,117,000 | 46,408,000 | 45,633,000 | 45,013,000 |
deferred lease income | 17,397,000 | 16,676,000 | 16,784,000 | 17,984,000 | 17,906,000 | 18,223,000 | 18,762,000 | 18,444,000 | 19,045,000 | 18,785,000 | 18,902,000 | 18,769,000 | 20,146,000 | 20,916,000 | 20,745,000 | 20,871,000 | 21,550,000 | 21,362,000 | 21,255,000 |
post-retirement obligations | 8,302,000 | 7,905,000 | 7,863,000 | 8,223,000 | 8,184,000 | 8,235,000 | 8,439,000 | 7,760,000 | 8,008,000 | 7,858,000 | 7,910,000 | 10,485,000 | 11,198,000 | 11,608,000 | 11,464,000 | 42,544,000 | 45,638,000 | 46,959,000 | 48,223,000 |
noncurrent liabilities | 7,150,000 | 5,474,000 | 4,418,000 | 9,285,000 | 8,762,000 | 8,728,000 | 8,879,000 | 12,415,000 | 12,626,000 | 15,051,000 | 12,831,000 | 15,345,000 | 15,668,000 | 16,188,000 | 16,274,000 | 19,300,000 | 18,905,000 | 18,795,000 | 17,506,000 |
total liabilities | 2,705,446,000 | 2,683,437,000 | 2,666,737,000 | 2,678,574,000 | 2,635,054,000 | 2,630,300,000 | 2,686,686,000 | 2,659,103,000 | 2,656,503,000 | 3,053,048,000 | 2,767,467,000 | 2,203,903,000 | 2,203,685,000 | 2,193,639,000 | 2,203,406,000 | 2,216,970,000 | 2,327,858,000 | 2,311,256,000 | 2,306,705,000 |
see commitments and contingencies note | |||||||||||||||||||
equity: | |||||||||||||||||||
common stock | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 |
preferred stock, with 0.01 par value, 120,000 shares authorized; no shares issued at june 30, 2025 and december 31, 2024 | |||||||||||||||||||
treasury stock | -19,038,000 | -20,855,000 | -23,434,000 | -24,612,000 | -24,764,000 | -26,042,000 | -27,182,000 | -28,474,000 | -28,700,000 | -29,420,000 | -29,775,000 | -32,653,000 | -32,654,000 | -33,536,000 | -33,545,000 | -34,000,000 | -34,000,000 | -34,000,000 | -34,000,000 |
additional paid-in capital | 1,251,089,000 | 1,244,841,000 | 1,243,778,000 | 1,238,899,000 | 1,229,428,000 | 1,220,547,000 | 1,215,178,000 | 1,210,346,000 | 1,202,972,000 | 1,195,357,000 | 1,189,622,000 | 1,186,620,000 | 1,181,995,000 | 1,177,097,000 | 1,172,593,000 | 1,171,104,000 | 1,167,566,000 | 1,169,852,000 | 1,166,412,000 |
retained deficit | -615,340,000 | -623,302,000 | -610,042,000 | -622,365,000 | -639,363,000 | -648,117,000 | -654,440,000 | -693,121,000 | -679,461,000 | -702,974,000 | -705,816,000 | -386,097,000 | -411,187,000 | -441,605,000 | -472,246,000 | -508,243,000 | -535,687,000 | -578,286,000 | -589,128,000 |
accumulated other comprehensive loss | -108,288,000 | -189,453,000 | -208,251,000 | -124,619,000 | -145,397,000 | -119,856,000 | -92,682,000 | -114,140,000 | -79,304,000 | -104,698,000 | -106,653,000 | -164,001,000 | -105,014,000 | -62,686,000 | -83,566,000 | -105,952,000 | -77,468,000 | -97,162,000 | -93,842,000 |
total equity | 511,283,000 | 414,091,000 | 404,911,000 | 470,163,000 | 422,764,000 | 429,392,000 | 443,734,000 | 377,471,000 | 418,367,000 | 361,125,000 | 350,238,000 | 606,729,000 | 636,000,000 | 642,130,000 | 586,096,000 | 525,769,000 | 523,271,000 | 465,744,000 | 454,574,000 |
total liabilities and equity | 3,216,729,000 | 3,097,528,000 | 3,071,648,000 | 3,148,737,000 | 3,057,818,000 | 3,059,692,000 | 3,130,420,000 | 3,036,574,000 | 3,074,870,000 | 3,414,173,000 | 3,117,705,000 | 2,810,632,000 | 2,839,685,000 | 2,835,769,000 | 2,789,502,000 | 2,742,739,000 | 2,851,129,000 | 2,777,000,000 | 2,761,279,000 |
deferred revenue | 13,754,000 | 15,100,000 | 10,653,000 | 12,882,000 | 13,492,000 | 12,712,000 | 15,161,000 | 12,140,000 | 5,347,000 | 12,928,000 | 8,669,000 | 4,866,000 | 5,539,000 | 5,958,000 | 6,056,000 | ||||
preferred stock, with 0.01 par value, 120,000 shares authorized; no shares issued at march 31, 2025 and december 31, 2024 | |||||||||||||||||||
preferred stock, with 0.01 par value, 120,000 shares authorized; no shares issued at december 31, 2024 and 2023 | |||||||||||||||||||
preferred stock, with 0.01 par value, 120,000 authorized; no shares issued at september 30, 2024 and december 31, 2023 | |||||||||||||||||||
preferred stock, with 0.01 par value, 120,000 authorized; no shares issued at june 30, 2024 and december 31, 2023 | |||||||||||||||||||
long-term debt, less current portion | 2,224,611,000 | 2,222,333,000 | 1,747,115,000 | 1,744,541,000 | 1,743,534,000 | 1,837,580,000 | 1,824,789,000 | ||||||||||||
preferred stock, with 0.01 par value, 120,000 authorized; no shares issued at march 31, 2024 and december 31, 2023 | |||||||||||||||||||
current portion of asset retirement obligations | 252,000 | 793,000 | 2,108,000 | 2,896,000 | 532,000 | 606,000 | 627,000 | 619,000 | 630,000 | 660,000 | 391,000 | 620,000 | |||||||
preferred stock, with 0.01 par value, 120,000 shares authorized; no shares issued at december 31, 2023 and 2022 | |||||||||||||||||||
preferred stock, with 0.01 par value, 120,000 authorized; no shares issued at september 30, 2023 and december 31, 2022 | |||||||||||||||||||
preferred stock, with 0.01 par value, 120,000 authorized; no shares issued at june 30, 2023 and december 31, 2022 | |||||||||||||||||||
preferred stock, with 0.01 par value, 120,000 authorized; no shares issued at march 31, 2023 and december 31, 2022 | |||||||||||||||||||
investment in unconsolidated affiliate | 9,550,000 | 9,405,000 | 9,396,000 | 9,373,000 | 9,227,000 | 13,457,000 | |||||||||||||
preferred stock, with 0.01 par value, 120,000 shares authorized; no shares issued at december 31, 2022 and 2021 | |||||||||||||||||||
total equity attributable to sotera health company | 350,238,000 | 606,729,000 | 636,000,000 | 642,130,000 | 586,096,000 | 525,769,000 | 523,271,000 | 463,264,000 | |||||||||||
noncontrolling interests | 2,480,000 | 2,272,000 | |||||||||||||||||
preferred stock, with 0.01 par value, 120,000 authorized no shares issued at september 30, 2022 and december 31, 2021, respectively | |||||||||||||||||||
preferred stock, with 0.01 par value, 120,000 authorized; no shares issued at june 30, 2022 and december 31, 2021, respectively | |||||||||||||||||||
post-retirement asset | 7,285,000 | 5,478,000 | |||||||||||||||||
preferred stock, with 0.01 par value, 120,000 authorized; no shares issued at march 31, 2022 and december 31, 2021, respectively | |||||||||||||||||||
mandatorily redeemable noncontrolling interest | 13,625,000 | ||||||||||||||||||
preferred stock, with 0.01 par value, 120,000 shares authorized, respectively; no shares issued | |||||||||||||||||||
preferred stock, with 0.01 par value, 120,000 authorized; no shares issued at september 30, 2021 and december 31, 2020, respectively | |||||||||||||||||||
preferred stock, with 0.01 par value, 120,000 authorized; no shares issued at june 30, 2021 and december 31, 2020, respectively | |||||||||||||||||||
preferred stock, with 0.01 par value, 120,000 authorized; no shares issued at march 31, 2021 and december 31, 2020, respectively | |||||||||||||||||||
preferred stock, with 0.01 par value, 120,000 and no shares authorized, respectively; no shares issued | |||||||||||||||||||
total equity (deficit) attributable to sotera health company | 452,302,000 | ||||||||||||||||||
revenues: | |||||||||||||||||||
service | 713,520,000 | ||||||||||||||||||
product | 104,638,000 | ||||||||||||||||||
total net revenues | 818,158,000 | ||||||||||||||||||
cost of revenues: | |||||||||||||||||||
total cost of revenues | 374,586,000 | ||||||||||||||||||
gross profit | 443,572,000 | ||||||||||||||||||
operating expenses: | |||||||||||||||||||
selling, general and administrative expenses | 178,525,000 | ||||||||||||||||||
amortization of intangible assets | 59,029,000 | ||||||||||||||||||
impairment of long-lived assets | |||||||||||||||||||
total operating expenses | 237,554,000 | ||||||||||||||||||
operating income | 206,018,000 | ||||||||||||||||||
interest expense | 215,259,000 | ||||||||||||||||||
loss on extinguishment of debt | 44,262,000 | ||||||||||||||||||
foreign exchange (gain) loss | -5,230,000 | ||||||||||||||||||
other income | -9,413,000 | ||||||||||||||||||
income before income taxes | -38,860,000 | ||||||||||||||||||
benefit for income taxes | -1,369,000 | ||||||||||||||||||
net income | -37,491,000 | ||||||||||||||||||
less: net income attributable to noncontrolling interests | 1,126,000 | ||||||||||||||||||
net income attributable to sotera health company | -38,617,000 | ||||||||||||||||||
other comprehensive income net of tax: | |||||||||||||||||||
pension and post-retirement benefits | -17,030,000 | ||||||||||||||||||
interest rate swaps | -179,000 | ||||||||||||||||||
foreign currency translation | 17,458,000 | ||||||||||||||||||
comprehensive income | -37,242,000 | ||||||||||||||||||
less: comprehensive income attributable to noncontrolling interests | 830,000 | ||||||||||||||||||
comprehensive loss attributable to sotera health company | -38,072,000 | ||||||||||||||||||
loss per share: | |||||||||||||||||||
basic and diluted | -160 | ||||||||||||||||||
weighted-average number of shares outstanding: |
We provide you with 20 years of balance sheets for Sotera Health stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Sotera Health. Explore the full financial landscape of Sotera Health stock with our expertly curated balance sheets.
The information provided in this report about Sotera Health stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.